Cargando…

The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a new acute espiratory infectious disease that has been in a public health emergency of international concern. In China, the combination of Xuanfei Baidu Formula (XBF) and conventional drug is used in the clinical treatment of patients with new coro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fan, Li, Yajuan, Zhang, Jingxia, Li, Shasha, Mao, Ajuan, Zhao, Chongbo, Wang, Weifeng, Li, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837860/
https://www.ncbi.nlm.nih.gov/pubmed/33546023
http://dx.doi.org/10.1097/MD.0000000000024129
_version_ 1783643040109297664
author Li, Fan
Li, Yajuan
Zhang, Jingxia
Li, Shasha
Mao, Ajuan
Zhao, Chongbo
Wang, Weifeng
Li, Fang
author_facet Li, Fan
Li, Yajuan
Zhang, Jingxia
Li, Shasha
Mao, Ajuan
Zhao, Chongbo
Wang, Weifeng
Li, Fang
author_sort Li, Fan
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) is a new acute espiratory infectious disease that has been in a public health emergency of international concern. In China, the combination of Xuanfei Baidu Formula (XBF) and conventional drug is used in the clinical treatment of patients with new coronary pneumonia, However, there is no comprehensive and systematic evidence on the effectiveness and safety of XBF. MATERIALS AND METHODS: We search for research in PubMed, China National Knowledge Infrastructure, Wan-fang Database, China Biomedical Database, and Chinese Science Citation Database. For “Xuanfei Baidu Formula” and “COVID-19,” we screened suitable articles without language restrictions on keywords, Review Manager 5.3 and STATA 14.2 software was used for the data analysis. RESULTS: The systematic review and meta-analysis will evaluate the efficacy and safety of XBF combined with conventional drug in the treatment of COVID-19. CONCLUSION: We will provide evidence of XBF for the treatment on COVID-19 patients. INPLASY REGISTRATION NUMBER: INPLASY2020120011
format Online
Article
Text
id pubmed-7837860
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78378602021-01-27 The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis Li, Fan Li, Yajuan Zhang, Jingxia Li, Shasha Mao, Ajuan Zhao, Chongbo Wang, Weifeng Li, Fang Medicine (Baltimore) 3800 BACKGROUND: Coronavirus disease 2019 (COVID-19) is a new acute espiratory infectious disease that has been in a public health emergency of international concern. In China, the combination of Xuanfei Baidu Formula (XBF) and conventional drug is used in the clinical treatment of patients with new coronary pneumonia, However, there is no comprehensive and systematic evidence on the effectiveness and safety of XBF. MATERIALS AND METHODS: We search for research in PubMed, China National Knowledge Infrastructure, Wan-fang Database, China Biomedical Database, and Chinese Science Citation Database. For “Xuanfei Baidu Formula” and “COVID-19,” we screened suitable articles without language restrictions on keywords, Review Manager 5.3 and STATA 14.2 software was used for the data analysis. RESULTS: The systematic review and meta-analysis will evaluate the efficacy and safety of XBF combined with conventional drug in the treatment of COVID-19. CONCLUSION: We will provide evidence of XBF for the treatment on COVID-19 patients. INPLASY REGISTRATION NUMBER: INPLASY2020120011 Lippincott Williams & Wilkins 2021-01-22 /pmc/articles/PMC7837860/ /pubmed/33546023 http://dx.doi.org/10.1097/MD.0000000000024129 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Li, Fan
Li, Yajuan
Zhang, Jingxia
Li, Shasha
Mao, Ajuan
Zhao, Chongbo
Wang, Weifeng
Li, Fang
The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
title The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
title_full The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
title_fullStr The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
title_full_unstemmed The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
title_short The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
title_sort therapeutic efficacy of xuanfei baidu formula combined with conventional drug in the treatment of coronavirus disease 2019: a protocol for systematic review and meta-analysis
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837860/
https://www.ncbi.nlm.nih.gov/pubmed/33546023
http://dx.doi.org/10.1097/MD.0000000000024129
work_keys_str_mv AT lifan thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT liyajuan thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT zhangjingxia thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT lishasha thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT maoajuan thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT zhaochongbo thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT wangweifeng thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT lifang thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT lifan therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT liyajuan therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT zhangjingxia therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT lishasha therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT maoajuan therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT zhaochongbo therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT wangweifeng therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis
AT lifang therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis